Tag: NIH

  • Foreign Components and Foreign Affiliations

    Foreign Components and Foreign Affiliations Over the past several months, Congress and federal funding agencies have voiced their concerns about the potential for improper foreign influence in U.S. academic research. On April 18, 2019, Dr. Bruner sent a “Dear Colleague” letter to the Emory research community. Highlights and Reminders To ensure complete disclosure, faculty should:…

  • NIH Announces Salary Cap for FY2019

    Effective Date: January 6, 2019 The HHS Appropriations Act provides authority for NIH to incur obligations for FY2019. This Act restricts the amount of direct salary to Executive Level II of the Federal Executive pay scale.  The Office of Personnel Management has recently released new salary levels for the Executive Pay Scale.  Effective January 6,…

  • New Webinars and Program Now Available in ELMS

    How to register: Register for the webinar/program in ELMS. To locate the webinar/program, please search using class code listed next to the corresponding webinar/program. Questions: Please contact Ashley Myers at aemyers@emory.edu.

  • Single IRB Review Reminder

    If your NIH RFA will involve collaborating sites, and NIH requires the use of a single IRB (“sIRB”), we remind you to consult with the Emory IRB very early on in the grant-writing process, and to not submit your sIRB plan without our prior review. We also remind you that reliance on an independent IRB is…

  • October is Biosafety Month

    by

    in

    2018 is the 5th anniversary of Biosafety Month. The National Institutes of Health’s (NIH) Office of Science Policy (OSP) initially created National Biosafety Month to encourage institutions to highlight the importance of biosafety and undertake activities to strengthen their biosafety programs. The 2018 Biosafety Month theme is “Promoting a Culture of Biosafety and Responsibility” with…

  • What is the Purpose of Personal Protective Equipment (PPE) in a Biological Research Facility?

    by

    in

    It’s really not a simple answer and requires an understanding of general biosafety. The World Health Organization (WHO) defines biosafety as principles, practices, and strategies aimed at minimizing the unintentional release of a biological agent. Biosafety is achieved by utilizing the four primary controls – engineering, PPE, standard operating procedures (SOPs), and administration. These controls…

  • Common Rule Delay and Single IRB Requirement for Federally Supported Studies

    On January 17, 2018, changes to the common rule that were scheduled to be effective on January 19, 2018, were delayed 6 months.  The new effective and compliance date is July 19, 2018.  This will allow time for the regulatory agencies to develop more guidance around the 2018 Common Rule, and they will also work…

  • Is it an Unliquidated or Unobligated Training Grant?

    Unliquidated vs. Unobligated, Training Grants A NIH Training grant is awarded to eligible institutions “to develop or enhance research training opportunities for individuals, selected by the institution, who are training for careers in specified areas of biomedical, behavioral and clinical research” (NIH Grants Policy Statement).  Training grants are commonly referenced by the acronym NRSA =…

  • Biological, Chemical and Chemicals in Animals Registrations/Forms Review in 2018

    by

    in

              The use of biological materials and chemicals in the laboratory or in animals require the review and approval of the Biosafety Office. Biological and Chemical Registrations, as well as, Chemicals in Animals Forms are maintained in BioRAFT. We are making efforts to synchronize the review of all modules to occur…

  • NIH ALERT: New NIH Submission Requirements Effective January 25, 2018

    To all Investigators proposing human subjects research to the NIH, For NIH submissions with due dates on or after January 25, 2018, it is imperative to make an accurate determination of whether your study meets the NIH definition of a clinical trial.  The NIH has broadly defined a “clinical trial” resulting in stringent requirements—some are…